The incidence, prevalence and clinical features of MECP2 duplication syndrome in Australian children

Peter Giudice-Nairn, Jenny Downs, Kingsley Wong, Dylan Wilson, Daniel Ta, Michael Gattas, David Amor, Elizabeth Thompson, Cathy Kirrali-Borri, Carolyn Ellaway, Helen Leonard

Research output: Contribution to journalArticle

Abstract

Aim: The aim of this study was to assess the incidence and prevalence of MECP2 duplication syndrome in Australian children and further define its phenotype. Methods: The Australian Paediatric Surveillance Unit was used to identify children with MECP2 duplication syndrome between June 2014 and November 2017. Reporting clinicians were invited to complete a questionnaire. Clinician data (n = 20) were supplemented with information from the International Rett Syndrome Phenotype Database and from caregivers (n = 7). Birth prevalence and diagnostic incidence were calculated. Results: The birth prevalence of MECP2 duplication syndrome in Australia was 0.65/100 000 for all live births and 1/100 000 for males. Diagnostic incidence was 0.07/100 000 person-years overall and 0.12/100 000 person-years for males. The median age at diagnosis was 23.5 months (range 0 months–13 years). A history of pneumonia was documented in three quarters of the clinical cases, half of whom had more than nine episodes. Cardiovascular abnormalities were reported in three cases. A clinical vignette is presented for one child who died due to severe idiopathic pulmonary hypertension. The majority (13/15) of males had inherited the duplication from their mothers, and two had an unbalanced translocation. Conclusions: MECP2 duplication syndrome is a rare but important diagnosis in children because of the burden of respiratory illness and recurrence risk. Pulmonary hypertension is a rare life-threatening complication. Array comparative genomic hybridisation testing is recommended for children with undiagnosed intellectual disability or global developmental delay. Early cardiac assessment and ongoing monitoring is recommended for MECP2 duplication syndrome.

Original languageEnglish
JournalJournal of Paediatrics and Child Health
DOIs
Publication statusE-pub ahead of print - 12 Feb 2019

Fingerprint

Incidence
Parturition
Cardiovascular Abnormalities
Rett Syndrome
Phenotype
Cost of Illness
Comparative Genomic Hybridization
Live Birth
Pulmonary Hypertension
Intellectual Disability
Caregivers
Pneumonia
Mothers
Lubs X-linked mental retardation syndrome
Databases
Pediatrics
Recurrence
Familial Primary Pulmonary Hypertension
Surveys and Questionnaires

Cite this

Giudice-Nairn, Peter ; Downs, Jenny ; Wong, Kingsley ; Wilson, Dylan ; Ta, Daniel ; Gattas, Michael ; Amor, David ; Thompson, Elizabeth ; Kirrali-Borri, Cathy ; Ellaway, Carolyn ; Leonard, Helen. / The incidence, prevalence and clinical features of MECP2 duplication syndrome in Australian children. In: Journal of Paediatrics and Child Health. 2019.
@article{a630c9dc09ed4b828d05bd514a5ef37f,
title = "The incidence, prevalence and clinical features of MECP2 duplication syndrome in Australian children",
abstract = "Aim: The aim of this study was to assess the incidence and prevalence of MECP2 duplication syndrome in Australian children and further define its phenotype. Methods: The Australian Paediatric Surveillance Unit was used to identify children with MECP2 duplication syndrome between June 2014 and November 2017. Reporting clinicians were invited to complete a questionnaire. Clinician data (n = 20) were supplemented with information from the International Rett Syndrome Phenotype Database and from caregivers (n = 7). Birth prevalence and diagnostic incidence were calculated. Results: The birth prevalence of MECP2 duplication syndrome in Australia was 0.65/100 000 for all live births and 1/100 000 for males. Diagnostic incidence was 0.07/100 000 person-years overall and 0.12/100 000 person-years for males. The median age at diagnosis was 23.5 months (range 0 months–13 years). A history of pneumonia was documented in three quarters of the clinical cases, half of whom had more than nine episodes. Cardiovascular abnormalities were reported in three cases. A clinical vignette is presented for one child who died due to severe idiopathic pulmonary hypertension. The majority (13/15) of males had inherited the duplication from their mothers, and two had an unbalanced translocation. Conclusions: MECP2 duplication syndrome is a rare but important diagnosis in children because of the burden of respiratory illness and recurrence risk. Pulmonary hypertension is a rare life-threatening complication. Array comparative genomic hybridisation testing is recommended for children with undiagnosed intellectual disability or global developmental delay. Early cardiac assessment and ongoing monitoring is recommended for MECP2 duplication syndrome.",
keywords = "developmental, genetics, intellectual disability, MECP2 duplication, population based",
author = "Peter Giudice-Nairn and Jenny Downs and Kingsley Wong and Dylan Wilson and Daniel Ta and Michael Gattas and David Amor and Elizabeth Thompson and Cathy Kirrali-Borri and Carolyn Ellaway and Helen Leonard",
year = "2019",
month = "2",
day = "12",
doi = "10.1111/jpc.14399",
language = "English",
journal = "Journal of Paediatric and Child Health",
issn = "1034-4810",
publisher = "John Wiley & Sons",

}

The incidence, prevalence and clinical features of MECP2 duplication syndrome in Australian children. / Giudice-Nairn, Peter; Downs, Jenny; Wong, Kingsley; Wilson, Dylan; Ta, Daniel; Gattas, Michael; Amor, David; Thompson, Elizabeth; Kirrali-Borri, Cathy; Ellaway, Carolyn; Leonard, Helen.

In: Journal of Paediatrics and Child Health, 12.02.2019.

Research output: Contribution to journalArticle

TY - JOUR

T1 - The incidence, prevalence and clinical features of MECP2 duplication syndrome in Australian children

AU - Giudice-Nairn, Peter

AU - Downs, Jenny

AU - Wong, Kingsley

AU - Wilson, Dylan

AU - Ta, Daniel

AU - Gattas, Michael

AU - Amor, David

AU - Thompson, Elizabeth

AU - Kirrali-Borri, Cathy

AU - Ellaway, Carolyn

AU - Leonard, Helen

PY - 2019/2/12

Y1 - 2019/2/12

N2 - Aim: The aim of this study was to assess the incidence and prevalence of MECP2 duplication syndrome in Australian children and further define its phenotype. Methods: The Australian Paediatric Surveillance Unit was used to identify children with MECP2 duplication syndrome between June 2014 and November 2017. Reporting clinicians were invited to complete a questionnaire. Clinician data (n = 20) were supplemented with information from the International Rett Syndrome Phenotype Database and from caregivers (n = 7). Birth prevalence and diagnostic incidence were calculated. Results: The birth prevalence of MECP2 duplication syndrome in Australia was 0.65/100 000 for all live births and 1/100 000 for males. Diagnostic incidence was 0.07/100 000 person-years overall and 0.12/100 000 person-years for males. The median age at diagnosis was 23.5 months (range 0 months–13 years). A history of pneumonia was documented in three quarters of the clinical cases, half of whom had more than nine episodes. Cardiovascular abnormalities were reported in three cases. A clinical vignette is presented for one child who died due to severe idiopathic pulmonary hypertension. The majority (13/15) of males had inherited the duplication from their mothers, and two had an unbalanced translocation. Conclusions: MECP2 duplication syndrome is a rare but important diagnosis in children because of the burden of respiratory illness and recurrence risk. Pulmonary hypertension is a rare life-threatening complication. Array comparative genomic hybridisation testing is recommended for children with undiagnosed intellectual disability or global developmental delay. Early cardiac assessment and ongoing monitoring is recommended for MECP2 duplication syndrome.

AB - Aim: The aim of this study was to assess the incidence and prevalence of MECP2 duplication syndrome in Australian children and further define its phenotype. Methods: The Australian Paediatric Surveillance Unit was used to identify children with MECP2 duplication syndrome between June 2014 and November 2017. Reporting clinicians were invited to complete a questionnaire. Clinician data (n = 20) were supplemented with information from the International Rett Syndrome Phenotype Database and from caregivers (n = 7). Birth prevalence and diagnostic incidence were calculated. Results: The birth prevalence of MECP2 duplication syndrome in Australia was 0.65/100 000 for all live births and 1/100 000 for males. Diagnostic incidence was 0.07/100 000 person-years overall and 0.12/100 000 person-years for males. The median age at diagnosis was 23.5 months (range 0 months–13 years). A history of pneumonia was documented in three quarters of the clinical cases, half of whom had more than nine episodes. Cardiovascular abnormalities were reported in three cases. A clinical vignette is presented for one child who died due to severe idiopathic pulmonary hypertension. The majority (13/15) of males had inherited the duplication from their mothers, and two had an unbalanced translocation. Conclusions: MECP2 duplication syndrome is a rare but important diagnosis in children because of the burden of respiratory illness and recurrence risk. Pulmonary hypertension is a rare life-threatening complication. Array comparative genomic hybridisation testing is recommended for children with undiagnosed intellectual disability or global developmental delay. Early cardiac assessment and ongoing monitoring is recommended for MECP2 duplication syndrome.

KW - developmental

KW - genetics

KW - intellectual disability

KW - MECP2 duplication

KW - population based

UR - http://www.scopus.com/inward/record.url?scp=85061443394&partnerID=8YFLogxK

U2 - 10.1111/jpc.14399

DO - 10.1111/jpc.14399

M3 - Article

JO - Journal of Paediatric and Child Health

JF - Journal of Paediatric and Child Health

SN - 1034-4810

ER -